Clinical trial
Empagliflozin in ESKD - A Feasibility Study
NCT05687058 is registered in ClinicalTrials.gov with University of Mississippi Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Empagliflozin in ESKD - A Feasibility Study
- Lead sponsor
- University of Mississippi Medical Center
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- November 1, 2023
- Completion date
- June 20, 2026
- Enrollment
- 24 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.